BioDtech Announces the Release of EndoPrep™
January 13, 2009
BioDtech, Inc. (BDTI) an emerging life science company, today announced the release of EndoPrep™, the first product designed for the safety of genetically engineered and protein drugs. EndoPrep™ allows for the more accurate detection of a toxin associated with the production of antibodies, recombinant proteins and synthetic peptides which are the basis for new cancer, [...]
Professor Yike Guo Becomes InforSense Chief Technology Officer
January 13, 2009
-Prof. Guo Steps Down as InforSense CEO, Remains Board Member I -nforSense Receives Commitment for Additional Capital of 5Mio USD investment from Major Investors, Including Executive Team, Following Two Consecutive Record Quarters and 30% Year-Over-Year Growth -David Bennett, Executive Vice President, Worldwide Sales, Appointed CEO -John O’Connell, Founder of Staffware, Continues as Executive Chairman of [...]
BioTek Instruments Establishes Office in United Kingdom
January 13, 2009
January 13, 2009, WINOOSKI VT, USA—BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Instruments Ltd. in the United Kingdom. The new organization will focus on growing BioTek’s brand and direct customer base in the UK while supporting the efforts of Thermo Fisher UK related to BioTek’s [...]
Pathwork Diagnostics Launches Version of Its Tissue of Origin Test for FFPE Specimens
January 13, 2009
New Version Increases Physician Access SUNNYVALE, Calif., Jan. 13 -- Pathwork Diagnostics, Inc., launched today an additional version of the Pathwork(R) Tissue of Origin Test that has the capability of analyzing formalin-fixed, paraffin-embedded (FFPE) tissue specimens. This molecular diagnostic test, which aids in the diagnosis of tumors with uncertain origins, is now available as a [...]
January 13, 2009
FREMONT, Calif.--DiscoveRx continues to innovate in field of GPCR signaling assays, tools and services and now has the largest and most comprehensive portfolio of assays and reagents for non-force coupled GPCR analysis. With a portfolio of over 300 validated assays for known and orphan GPCRs along with HitHunter™ second messenger and PathHunter™ ß-Arrestin assays and [...]
TRADE NEWS: Agilent Technologies Adds Custom miRNA Capability to Online Microarray Design Tool
January 13, 2009
Agilent Technologies Inc. (NYSE:A), today announced the release of eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) microarrays. miRNA is a rapidly emerging field of study because researchers are increasingly associating these abundant molecules with some types of cancers, heart disease, other disorders and stem-cell differentiation. Researchers can use [...]
EXACT Sciences Board of Directors Rejects Acquisition Proposal from Sequenom, Inc.
January 12, 2009
MARLBOROUGH, Mass.--EXACT Sciences Corporation (NASDAQ: EXAS) announced that its Board of Directors has unanimously rejected an acquisition proposal by Sequenom, Inc. (NASDAQ: SQNM) to acquire EXACT for $1.50 per share in Sequenom common stock, subject to a collar. The Board, after reviewing the proposal with its financial and legal advisors, has determined to reject the [...]
Thermo Fisher Scientific Launches the Most Compact Modular Total Nitrogen/Sulfur/Chlorine Analyzer
January 12, 2009
DELFT, Netherlands (January 12, 2009) - Thermo Fisher Scientific Inc., the world leader in serving science, announces the launch of the new TITAN 4000 Total Nitrogen/Sulfur/Chlorine (NSX) analyzer. This streamlined NSX analyzer, up to 60% smaller than competing analyzers, offers users in the refinery and petrochemical markets superior sample introduction and enhanced oxidative combustion performance. [...]
January 12, 2009
FREMONT, Calif., Jan. 12 -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that academic researchers have successfully demonstrated the performance of the company's SmartChip(TM) Real-Time PCR System in the initial phase of the platform's ongoing alpha testing program. [...]
Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement
January 12, 2009
Illumina (NASDAQ:ILMN) and Oxford Nanopore Technologies (“Oxford Nanopore”) today announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford Nanopore for DNA sequencing into the research and diagnostic markets on a worldwide basis. [...]
